Siemens Healthineers has entered a co-marketing agreement with Hill-Rom to deliver comprehensive point-of-care diagnostic tools for primary healthcare providers to enhance diabetes care.
The collaboration covers Siemens Healthineers DCA Vantage Analyzer for HbA1c testing and CLINITEK Status+ Urine Chemistry Analyzer for kidney checks, along with Hill-Rom’s Welch Allyn RetinaVue Network and imaging technology for teleretinal exams.
This patient-centred offering can provide physicians with more control over patient care by enabling proactive testing and treatment within a single visit.
The enhanced workflow is expected to minimise costs and eliminate the inconvenience associated with follow-up visits, resulting in better patient satisfaction and compliance with care regimens.
Siemens Healthineers North America Point of Care Diagnostics senior vice-president Mike Sampson said: “Our new commercial relationship with Hill-Rom will provide holistic, easy-to-implement solutions that aid in combating diabetes and related comorbidities while satisfying value-based quality care measures.
“With operator-friendly analysers that generate lab-quality results in minutes and capabilities to integrate test results with electronic health records, physicians can make immediate treatment decisions and improve long-term outcomes.”
The company’s DCA Vantage Analyzer monitors glycaemic control through HbA1c testing, while the CLINITEK Status+ Urine Chemistry Analyzer can be used for a rapid kidney check in 60 seconds with albumin-to-creatinine ratio testing.
Hill-Rom Front Line Care business president Alton Shader said: “Hill-Rom and Siemens Healthineers share a common vision to put patients on a better path to healthcare by providing solutions that allow our customers to transform care delivery with greater efficiency and effectiveness.”
Hill-Rom Welch Allyn RetinaVue Network is designed for in-office diabetic retinal exams and captures images using nonmydriatic cameras within seconds. These images are transmitted via software for interpretation by a nationwide team of ophthalmologists.